1. Home
  2. LXFR vs PRTC Comparison

LXFR vs PRTC Comparison

Compare LXFR & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$15.88

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.44

Market Cap

400.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
PRTC
Founded
1898
2015
Country
United States
United States
Employees
N/A
90
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
400.2M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
LXFR
PRTC
Price
$15.88
$17.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.1K
9.1K
Earning Date
04-28-2026
04-29-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$384,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.01
N/A
P/E Ratio
$122.19
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$10.96
$14.50
52 Week High
$16.03
$19.92

Technical Indicators

Market Signals
Indicator
LXFR
PRTC
Relative Strength Index (RSI) 78.43 51.53
Support Level $11.55 $16.51
Resistance Level $16.00 $18.34
Average True Range (ATR) 0.53 0.66
MACD 0.29 -0.10
Stochastic Oscillator 96.80 28.00

Price Performance

Historical Comparison
LXFR
PRTC

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: